Jacobus Enslin
Jacobus Enslin @Enslinjaco

Performance
2026

8.31%0.00-8.31%
2.58%
August 2026
1.85%
July 2026
-8.31%
June 2026
5.49%
May 2026
4.62%
April 2026
-7.36%
March 2026
-4.90%
February 2026
5.28%
January 2026
Dec December
Nov November
Oct October
Sep September
Aug August
Jul July
Jun June
May May
Apr April
Mar March
Feb February
Jan January
-1.94%
2.58%
1.85%
-8.31%
5.49%
4.62%
-7.36%
-4.90%
5.28%
2026
38.87%
0.85%
-5.43%
0.31%
12.11%
15.36%
0.88%
13.14%
8.19%
-1.69%
-7.48%
-2.56%
2.54%
2025
-1.96%
-4.98%
2.30%
-1.47%
5.78%
-1.67%
3.68%
-6.26%
2.30%
-1.08%
1.40%
-2.31%
1.01%
2024
23.79%
7.23%
0.20%
-3.14%
2.17%
-1.32%
15.19%
8.44%
-7.37%
-1.39%
-1.97%
-0.77%
6.28%
2023
37.03%
-4.73%
4.30%
10.41%
-8.43%
3.97%
5.39%
-7.76%
10.19%
-1.85%
3.81%
5.95%
13.46%
2022
14.02%
3.04%
-3.72%
6.96%
6.45%
0.94%
-5.17%
-0.46%
3.34%
1.87%
0.64%
2021
Trading since3/12/21 Show More
Past performance is not indicative of future results. Stats are updated on a daily basis at 00:00 GMT.

Breakdown

This breakdown includes 92.9% of this Portfolio

Asset Type

Portfolio Risk (1Y)

Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Avg. Risk Score (last 7D)5
Daily Max. Drawdown-3.37%
Weekly Max. Drawdown-5.09%
Yearly Max. Drawdown-16.73%

Expected Dividends

Dividend Yield

0.63%

5 Assets

Dividend Logo
Dividend Logo
Dividend Logo

+2 more

Trading

93 Total Trades (12M)
52.25% Avg. Profit
-36.83% Avg. Loss
58.06% Profitable Trades

Frequently Traded

BFIT.NV
35.49% Avg. Profit
0% Avg. Loss
100.00%Profitable
VTY.L
2.71% Avg. Profit
-39.93% Avg. Loss
10.00%Profitable
PRGO
0% Avg. Profit
-56.48% Avg. Loss
0%Profitable

Additional Stats

1.75
Trades Per Week
16 Months Avg. Holdings time
3/12/21 Active since
48.15% Profitable weeks

Copiers (12M)

2220
Content, research, tools, and stock symbols on etoro's website are for educational purposes only and do not imply a recommendation or solicitation to engage in any specific investment strategy. All investments involve risk, losses may exceed the amount of principal invested, and past performance does not guarantee future results.